GMVAX | VIMSX | GMVAX / VIMSX | |
Total Expense Ratio | 1.18 | 0.17 | 694% |
Annual Report Gross Expense Ratio | 1.44 | 0.17 | 847% |
Fund Existence | 12 years | 27 years | - |
Gain YTD | 0.734 | 9.695 | 8% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 141M | 201B | 0% |
Annual Yield % from dividends | 0.78 | 1.36 | 57% |
Returns for 1 year | -3.17 | 7.57 | -42% |
Returns for 3 years | 17.44 | 49.65 | 35% |
Returns for 5 years | 41.76 | 57.21 | 73% |
Returns for 10 years | 62.20 | 140.60 | 44% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
TIEWX | 16.94 | 0.08 | +0.47% |
Nuveen International Eq W | |||
CMVIX | 29.31 | 0.11 | +0.38% |
BlackRock Advantage Large Cap Gr Instl | |||
MSDQX | 15.67 | N/A | N/A |
Morgan Stanley Emerging Mkt ex China A | |||
MSCYX | 14.84 | -0.03 | -0.20% |
MassMutual Small Cap Gr Eq Svc | |||
MSAAX | 20.71 | -0.09 | -0.43% |
Morgan Stanley Inst Passport ovrs eq C |